Literature DB >> 32364599

Patterns of Influenza Vaccination and Vaccine Effectiveness Among Young US Children Who Receive Outpatient Care for Acute Respiratory Tract Illness.

Jessie R Chung1, Brendan Flannery1, Manjusha Gaglani2,3, Michael E Smith3, Evelyn C Reis4, Robert W Hickey5, Michael L Jackson6, Lisa A Jackson6, Edward A Belongia7, Huong Q McLean7, Emily T Martin8, Hannah E Segaloff8, Sara S Kim1, Manish M Patel1.   

Abstract

Importance: The burden of influenza among young children is high, and influenza vaccination is the primary strategy to prevent the virus and its complications. Less is known about differences in clinical protection following 1 vs 2 doses of initial influenza vaccination.
Objectives: To describe patterns of influenza vaccination among young children who receive outpatient care for acute respiratory tract illness in the US and compare vaccine effectiveness (VE) against medically attended laboratory-confirmed influenza by number of influenza vaccine doses received. Design: This test-negative case-control study was conducted in outpatient clinics, including emergency departments, at 5 sites of the US Influenza Vaccine Effectiveness Network during the 2014-2015 through 2017-2018 influenza seasons. The present study was performed from November 5, 2014, to April 12, 2018, during periods of local influenza circulation. Children aged 6 months to 8 years with an acute respiratory tract illness with cough who presented for outpatient care within 7 days of illness onset were included. All children were tested using real-time, reverse-transcriptase polymerase chain reaction for influenza for research purposes. Exposures: Vaccination in the enrollment season with either 1 or 2 doses of inactivated influenza vaccine as documented from electronic medical records, including state immunization information systems. Main Outcomes and Measures: Medically attended acute respiratory tract infection with real-time, reverse-transcriptase polymerase chain reaction testing for influenza.
Results: Of 7533 children, 3480 children (46%) were girls, 4687 children (62%) were non-Hispanic white, and 4871 children (65%) were younger than 5 years. A total of 3912 children (52%) were unvaccinated in the enrollment season, 2924 children (39%) were fully vaccinated, and 697 children (9%) were partially vaccinated. Adjusted VE against any influenza was 51% (95% CI, 44%-57%) among fully vaccinated children and 41% (95% CI, 25%-54%) among partially vaccinated children. Among 1519 vaccine-naive children aged 6 months to 2 years, the VE of 2 doses in the enrollment season was 53% (95% CI, 28%-70%), and the VE of 1 dose was 23% (95% CI, -11% to 47%); those who received 2 doses were less likely to test positive for influenza compared with children who received only 1 dose (adjusted odds ratio, 0.57; 95% CI, 0.35-0.93). Conclusions and Relevance: Consistent with US influenza vaccine policy, receipt of the recommended number of doses resulted in higher VE than partial vaccination in 4 influenza seasons. Efforts to improve 2-dose coverage for previously unvaccinated children may reduce the burden of influenza in this population.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32364599      PMCID: PMC7199168          DOI: 10.1001/jamapediatrics.2020.0372

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   16.193


  28 in total

1.  Economic impact of influenza vaccination in preschool children.

Authors:  G M Cohen; M D Nettleman
Journal:  Pediatrics       Date:  2000-11       Impact factor: 7.124

2.  Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children.

Authors:  Kathleen M Neuzil; Lisa A Jackson; Jennifer Nelson; Alexander Klimov; Nancy Cox; Carolyn B Bridges; John Dunn; Frank DeStefano; David Shay
Journal:  J Infect Dis       Date:  2006-09-11       Impact factor: 5.226

3.  Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed influenza illness in US children, 2010-2012.

Authors:  Jill M Ferdinands; Lauren E W Olsho; Anna A Agan; Niranjan Bhat; Ryan M Sullivan; Mark Hall; Peter M Mourani; Mark Thompson; Adrienne G Randolph
Journal:  J Infect Dis       Date:  2014-03-26       Impact factor: 5.226

4.  Effectiveness of Partial and Full Influenza Vaccination Among Children Aged <9 Years in Hong Kong, 2011-2019.

Authors:  Huiying Chua; Susan S Chiu; Eunice L Y Chan; Shuo Feng; Mike Y W Kwan; Joshua S C Wong; J S Malik Peiris; Benjamin J Cowling
Journal:  J Infect Dis       Date:  2019-10-08       Impact factor: 5.226

5.  Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection.

Authors:  Krow Ampofo; Per H Gesteland; Jeffery Bender; Michelle Mills; Judy Daly; Matthew Samore; Carrie Byington; Andrew T Pavia; Rajendu Srivastava
Journal:  Pediatrics       Date:  2006-12       Impact factor: 7.124

6.  Potential cost savings attributable to influenza vaccination of school-aged children.

Authors:  T White; S Lavoie; M D Nettleman
Journal:  Pediatrics       Date:  1999-06       Impact factor: 7.124

7.  Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?

Authors:  Emmanuel B Walter; Kathleen M Neuzil; Yuwei Zhu; Mary P Fairchok; Martha E Gagliano; Arnold S Monto; Janet A Englund
Journal:  Pediatrics       Date:  2006-09       Impact factor: 7.124

8.  Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season.

Authors:  Mandy A Allison; Matthew F Daley; Lori A Crane; Jennifer Barrow; Brenda L Beaty; Norma Allred; Stephen Berman; Allison Kempe
Journal:  J Pediatr       Date:  2006-12       Impact factor: 4.406

9.  Prevention and Control of Seasonal Influenza with Vaccines.

Authors:  Lisa A Grohskopf; Leslie Z Sokolow; Karen R Broder; Sonja J Olsen; Ruth A Karron; Daniel B Jernigan; Joseph S Bresee
Journal:  MMWR Recomm Rep       Date:  2016-08-26

10.  Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses.

Authors:  Mark G Thompson; Jessie Clippard; Joshua G Petrie; Michael L Jackson; Huong Q McLean; Manjusha Gaglani; Evelyn C Reis; Brendan Flannery; Arnold S Monto; Lisa Jackson; Edward A Belongia; Kempapura Murthy; Richard K Zimmerman; Swathi Thaker; Alicia M Fry
Journal:  Pediatr Infect Dis J       Date:  2016-03       Impact factor: 2.129

View more
  7 in total

1.  A Retrospective Test-Negative Case-Control Study to Evaluate Influenza Vaccine Effectiveness in Preventing Hospitalizations in Children.

Authors:  Inci Yildirim; Carol M Kao; Ashley Tippett; Piyarat Suntarattiwong; Mohamed Munye; Jumi Yi; Mohnd Elmontser; Elizabeth Quincer; Chris Focht; Nora Watson; Hande Bilen; Julia M Baker; Ben Lopman; Elena Hogenesch; Christina A Rostad; Evan J Anderson
Journal:  Clin Infect Dis       Date:  2021-11-16       Impact factor: 20.999

2.  Epipharyngeal Abrasive Therapy Down-regulates the Expression of Cav1.2: A Key Molecule in Influenza Virus Entry.

Authors:  Kensuke Nishi; Shohei Yoshimoto; Soichiro Nishi; Tatsuro Nishi; Ryushiro Nishi; Toshiyuki Tsunoda; Hiromitsu Morita; Hiroaki Tanaka; Osamu Hotta; Susumu Yasumasu; Kenji Hiromatsu; Senji Shirasawa; Takashi Nakagawa; Takafumi Yamano
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

3.  Drivers of Infectious Disease Seasonality: Potential Implications for COVID-19.

Authors:  N Kronfeld-Schor; T J Stevenson; S Nickbakhsh; E S Schernhammer; X C Dopico; T Dayan; M Martinez; B Helm
Journal:  J Biol Rhythms       Date:  2021-01-24       Impact factor: 3.182

4.  Influenza's plummeting during the COVID-19 pandemic: The roles of mask-wearing, mobility change, and SARS-CoV-2 interference.

Authors:  Shasha Han; Ting Zhang; Yan Lyu; Shengjie Lai; Peixi Dai; Jiandong Zheng; Weizhong Yang; Xiao-Hua Zhou; Luzhao Feng
Journal:  Engineering (Beijing)       Date:  2022-02-02       Impact factor: 7.553

5.  Clinical manifestations and outcome of viral acute lower respiratory infection in hospitalised children in Myanmar.

Authors:  Kazuhiro Kamata; Khin Nyo Thein; Lasham Di Ja; Nay Chi Win; Su Mon Kyaw Win; Yuko Suzuki; Ai Ito; Hidekazu Osada; Irina Chon; Wint Wint Phyu; Yuta Aizawa; Tatsuki Ikuse; Tomomi Ota; Yadanar Kyaw; Htay Htay Tin; Yugo Shobugawa; Hisami Watanabe; Reiko Saito; Akihiko Saitoh
Journal:  BMC Infect Dis       Date:  2022-04-08       Impact factor: 3.090

6.  Trends in effectiveness of inactivated influenza vaccine in children by age groups in seven seasons immediately before the COVID-19 era.

Authors:  Masayoshi Shinjoh; Munehiro Furuichi; Hisato Kobayashi; Yoshio Yamaguchi; Naonori Maeda; Mizuki Yaginuma; Ken Kobayashi; Taisuke Nogayama; Michiko Chiga; Mio Oshima; Yuu Kuramochi; Go Yamada; Atsushi Narabayashi; Ichiro Ookawara; Mitsuhiro Nishida; Kenichiro Tsunematsu; Isamu Kamimaki; Motoko Shimoyamada; Makoto Yoshida; Akimichi Shibata; Yuji Nakata; Nobuhiko Taguchi; Keiko Mitamura; Takao Takahashi
Journal:  Vaccine       Date:  2022-04-11       Impact factor: 4.169

7.  Influenza Vaccination Effectiveness in Paediatric 'Healthy' Patients: A Population-Based Study in Italy.

Authors:  Anna Cantarutti; Elisa Barbieri; Fabio Didonè; Antonio Scamarcia; Carlo Giaquinto; Giovanni Corrao
Journal:  Vaccines (Basel)       Date:  2022-04-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.